Intrinsic Value of S&P & Nasdaq Contact Us

UnitedHealth Group Incorporated UNH NYSE

NYSE • Healthcare • Medical - Healthcare Plans • US • USD

SharesGrow Score
58/100
3/7 Pass
SharesGrow Intrinsic Value
$902.20
+187.2%
Analyst Price Target
$385.38
+22.7%

UnitedHealth Group Incorporated (UNH) generated $1.11B in operating cash flow for quarter ending 2025-12-31. After capital expenditures of $948M, free cash flow was $160M.

Free cash flow margin was 0.1% of revenue. Cash conversion ratio was 5.08x, indicating earnings are backed by cash.

The company returned $2B in dividends and $4.74B in share buybacks to shareholders during the quarter.

Criteria supported by this page:

  • HEALTH (33/100, Fail) — weak cash flow raises concerns about debt servicing
  • MOAT (51/100, Partial) — cash flow generation is present but not at levels indicating a wide moat
  • INCOME (30/100) — Cash conversion ratio was 5.08x confirms earnings are backed by real cash flow

Overall SharesGrow Score: 58/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
58/100
SG Score
View full scorecard →
VALUE
66/100
Price-to-Earnings & upside
→ Valuation
FUTURE
79/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
HEALTH
33/100
Debt-to-Equity & liquidity
Proven by this page
~
MOAT
51/100
Proven by this page
~
GROWTH
48/100
→ Income
INCOME
30/100
→ Income
UnitedHealth Group Incorporated Cash Flow History
Metric TTM Q4 FY2025 Q3 FY2025 Q2 FY2025 Q1 FY2025
Operating Cash Flow $19.7B$1.11B$5.95B$7.19B$5.46B
Capital Expenditure $-3.62B$-948M$-890M$-886M$-898M
Free Cash Flow $16.08B$160M$5.06B$6.3B$4.56B
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message